Nivolumab-induced large-duct cholangiopathy treated with ursodeoxycholic acid and tocilizumab

Immunotherapy, Ahead of Print.

Source: Immunotherapy - December 3, 2019 Category: Allergy & Immunology Authors: Chanakyaram A Reddy Bryan J Schneider Lindsay M Brackett Andrew W Tai Source Type: research